Compounding for animal patients: Contemporary issues

Journal of the American Pharmacists Association

Volumn 44, Issue 3, 2004, Pages 375-386

  Lust, Elaine ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Animal compounding; Animal health; Compounding; Contemporary compounding; Veterinary compounding; Veterinary medicine; Veterinary pharmacy

Indexed keywords

VETERINARY DRUG;

ALGORITHM; ANIMAL; ANIMAL DISEASE; DRUG FORMULATION; LAW; REVIEW; UNITED STATES;

ALGORITHMS; ANIMALS; DRUG COMPOUNDING; LEGISLATION, PHARMACY; UNITED STATES; VETERINARY DRUGS;

EID: 2942729858     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434504323064011     Document Type: Article

References (53)

1. Navarro R. Managed care pharmacy practice. Gaithersburg, Md.: Aspen Publishers; 1999:452-3.
2. Miller CE. Veterinary compounding for ferrets. Intl J Pharm Compound. 2002;6:136-9.
3. Bone C. Simplified guide to veterinary compounding. Intl J Pharm Compound. 2001;5:104.
4. Fan B, Stewart JT, White CA. Stability and dissolution of lozenge and emulsion formulations of metronidazole benzoate. Intl J Pharm Compound. 2001;5:153-6.
5. Yoakum J. Compounded injectables for veterinary use. Intl J Pharm Compound. 2001;5:107.
6. Ahl H. Equipment for large volume aseptic veterinary compounding. Intl J Pharm Compound. 2001;5:106.
7. Allen LV. Antiseptic ointment for use in animals. US Pharm. 1999;24:68-70.
8. Paoletti JE. Veterinary flavor suggestions. Intl J Pharm Compound. 1999;3:186-7.
9. Davis J. Compounding for creatures; what works. Intl J Pharm Compound. 1999;3:182-5.
10. Anonymous. Compounding and the specialty veterinary practice. Intl J Pharm Compound. 1999;3:172-5.
11. Havlick HD. Compounding of nutraceuticals. J Am Nutraceut Assn. 1998;1:35-6.
12. Franck PW, Allen C, Clark C. Veterinary considerations: COPD in horses. Intl J Pharm Compound. 1998;2:420.
13. Paoletti J, Downing D, Tormo VJ. Feasibility and benefits of TPN in horses: review of the findings. Intl J Pharm Compound. 1998;2:351-3.
14. Franck PW. Ophthalmic compounding for animals: equine ophthalmic ointments. Intl J Pharm Compound. 1998;2:206-7.
15. Patterson D. Osteomyelitis in a young draft horse. Intl J Pharm Compound. 1997;1:242,284-5.
16. Timmons SP. Compounding for degenerative myelopathy in the German shepherd. Intl J Pharm Compound. 1997;1:241,284-5.
17. Ford PR, Gallon MD. 12-year old quarter horse gelding with chronic obstructive pulmonary disease. Intl J Pharm Compound. 1997;1:242-3,284-5.
18. Compounding for veterinary patients: pharmaceutical, biopharmaceutical, pharmacokinetic and physiologic considerations. Intl J Pharm Compound. 1997;1:233-4,284-5.
19. Bradley EW. Improving profitability with veterinary compounding. Intl J Pharm Compound 1999;3:180-1.
20. Compliance Policy Guide Section 608.400, Compounding of drugs for use in animals. Accessed at www.fda.gov/cvm, September 15, 2003.
21. 21 CFR Part 530. Extralabel drug use in animals. The Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA). Accessed at www.fda.gov/cvm, February 20, 2003.
22. Compounding in veterinary medicine. Symposium proceedings and task force reports. J Am Vet Med Assoc. 1994;205:189-303.
23. Drug compounding position statement adopted. J Am Vet Med Assoc. 2001:218. Accessed at www.avma.org/policies/compounding.htm, May 1, 2003.
24. Lust E. Veterinary compounding raises critical issues. Pharm Today. 2003(Feb);9(2):7.
25. Wiebe VJ. We need compounding controls. Drug Topics. September 16, 2002:12.
26. Extralabel Drug Use Algorithm, AMDUCA guidance brochure. Schaumburg, Ill.: American Veterinary Medical Association; 2001. Accessed at www.avma.org/scienact/amduca/amduca1.asp, January 27, 2004.
27. Stowe CM. Dynamics of preparation of parenteral and other drugs by veterinary practitioners. J Am Vet Med Assoc. 1988;192:262-4.
28. Raef TA. FDA-CVM asks for veterinary input on responsible compounding of drugs. J Am Vet Med Assoc. 1990;197:967.
29. Guidelines for pharmaceutical compounding. J Am Vet Med Assoc. 1992;200:172-3.
30. Compounding forum: FDA-CVM hears veterinarians views. J Am Vet Med Assoc. 1993;230:1367-72.
31. Upson D. AVMA guidelines on compounding. J Am Vet Med Assoc. 1994;205;199-200.
32. Compounding for animals: AVMA perspective. Intl J Pharm Compound. 1997;1:230-2,284-5.
33. Davis S. Compounding takes center stage at FDA. DVM News Magazine. 2002(Sept);1:38-9.
34. Drug compounding position statement adopted. J Am Vet Med Assoc. 2001:218. Accessed at www.avma.org/policies/compounding.htm, May 5, 2003.
35. 21 CFR Part 530. Extralabel drug use in animals. The Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA). Accessed at www.fda.gov/cvm, February 20, 2003.
36. Papich MG. Bayer Exotics Symposium, North American Veterinary Conference. Old drugs and new thoughts in exotic medicine. Suppl Compend Contin Educ Pract Vet. 2003;25:5-14.
37. Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in health cats. J Vet Pharmacol Ther. 2002;25:189-93.
38. Hoffman G, Marks SL, Taboada J, et al. Transdermal methimazole treatment in cats with hyperthyroidism. J Fel Med Surg. 2003;2:77-82.
39. Wingate G. Transdermal methimazole in the treatment of 16 cats with hyperthyroidism. Intl J Pharm Compound. 2002;6:344-5
40. Fondon L. Small animal veterinary drug compounding survey results. Dallas, Tex.: Brakke Consulting Inc.; 2003.
41. Internet Pharmacies and compounding are high priority areas, say FDA. J Am Vet Med Assoc. 2002(Mar 15).
42. Rollin BE. An ethicist's commentary on veterinarians producing autogenous vaccines and compounding antimicrobial drugs. Can Vet J. 2002;43:164.
43. Fajt VR. Compounding: What's legal, what's not. Bovine Veterinarian. 2003;March/April:26-32.
44. Compliance Policy Guide Section 460.200, Pharmacy compounding. Accessed at www.fda.gov, March 25, 2003.
45. Update on Illegal compounding of clenbuterol veterinary drug products. Food and Drug Administration, Center for Veterinary Medicine. Accessed at www.fda.gov/cvm/index/updates/clenbut.htm, January 10, 2002.
46. Maye DE, Pipers F, Hurtig FS. Diminishing returns: compounded omeprazole products found to have little or no value [veterinary bulletin]. Iselin, N.J.: Merial Veterinary Professional Services, Merial Ltd; February 2001.
47. Newsletter of the American Association of Veterinary State Boards. "Veterinary VIPPS Program, AAVSB and NABP Sign Memorandum of Understanding." 2003:8(2). Accessed at www.aavsb.org/news/Spring News2003.pdf, May 1, 2003.
48. National Association of Boards of Pharmacy. Verified Internet Pharmacy Practice Sites. Online pharmacy provider criteria. Accessed at http://vipps.nabp.net/verify.asp, May 1, 2003.
49. Online courses in Veterinary Therapeutics for Practicing Pharmacists and Pharmacy Students. Creighton University School of Pharmacy and Health Professions. Accessed at http://pharmacy.creighton.edu, September 18, 2003.
50. American College of Veterinary Pharmacists. Accessed at www.vetmeds.org, September 18, 2003.
51. Professional Compounding Centers of America. Accessed at www.pccarx.com, September 18, 2003.
52. Gallipot Training Seminars. Accessed at www.gallipot.com/education.asp, March 23, 2004.
53. Residency Program in Veterinary Clinical Pharmacy. University of California-Davis, Veterinary Medical Teaching Hospital. Accessed at www.vmth.ucdavis.edu/vmth/residency/supres/pharmacy.html, September 18, 2003.